Viewing Study NCT01273402

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-01-31 @ 11:47 PM
Study NCT ID: NCT01273402
Status: WITHDRAWN
Last Update Posted: 2021-08-16
First Post: 2011-01-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer
Sponsor: Gilead Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None colorectal cancer View
None TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 … View
None IMP288 (DOTA-di-HSG hapten-peptide for 111In/90Y labeling) View